Intense correlation between brain infarction and protein-conjugated acrolein

Stroke

Volumn 40, Issue 10, 2009, Pages 3356-3361

  Saiki, Ryotaro ^a   Nishimura, Kazuhiro ^a   Ishii, Itsuko ^a   Omura, Tomohiro ^b   Okuyama, Shigeru ^b   Kashiwagi, Keiko ^c   Igarashi, Kazuei ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

^c CHIBA INSTITUTE OF SCIENCE   (Japan)

Author keywords

Acrolein; Brain infarction; Neuroprotective agents; Polyamines; Risk factors

Indexed keywords

ACETYLCYSTEINE; ACROLEIN; POLYAMINE; POLYAMINE OXIDASE; SPERMIDINE; SPERMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WESTERN BLOTTING;

ACETYLCYSTEINE; ACROLEIN; ANIMALS; BRAIN; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FREE RADICAL SCAVENGERS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; PHOTOCHEMISTRY; ROSE BENGAL; SPERMIDINE; SPERMINE; TIME FACTORS; UP-REGULATION;

EID: 70349658526     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.553248     Document Type: Article

References (30)

1. Tomitori H, Usui T, Saeki N, Ueda S, Kase H, Nishimura K, Kashiwagi K, Igarashi K. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke. 2005;36:2609-2613.
2. Yoshida M, Tomitori H, Machi Y, Katagiri D, Ueda S, Horiguchi K, Kobayashi E, Saeki N, Nishimura K, Ishii I, Kashiwagi K, Igarashi K. Acrolein, IL-6 and CRP as markers of silent brain infarction. Atherosclerosis. 2009;203:557-562.
3. Giorgio M, Trinei M, Migliaccio E, Pelicci PG. Hydrogen peroxide: a metabolic by-product or a common mediator of aging signals? Nat Rev Mol Cell Biol. 2007;8:722-728.
4. Sharmin S, Sakata K, Kashiwagi K, Ueda S, Iwasaki S, Shirahata A, Igarashi K. Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem Biophys Res Commun. 2001;282:228-235.
5. Yoshida M, Tomitori H, Machi Y, Hagihara M, Higashi K, Goda H, Ohya T, Niitsu M, Kashiwagi K, Igarashi K. Acrolein toxicity: comparison with reactive oxygen species. Biochem Biophys Res Commun. 2009;378: 313-318.
6. Uchida K, Kanematsu M, Morimitsu Y, Osawa T, Noguchi N, Niki E. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J Biol Chem. 1998;273:16058-16066.
7. Igarashi K, Kashiwagi K. Breakthrough and Views: polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun. 2000;271:559-564.
8. Kimes BW, Morris DR. Preparation and stability of oxidized polyamines. Biochim Biophys Acta. 1971;228:223-234.
9. Wang Y, Casero RA Jr. Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both? J Biochem (Tokyo). 2006;139: 17-25.
10. Tanaka Y, Marumo T, Omura T, Yoshida S. Quantitative assessments of cerebral vascular damage with a silicon rubber casting method in photochemically-induced thrombotic stroke rat models. Life Sci. 2007; 81:1381-1388.
11. Fujii S, Hitomi Y. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin. Biochim Biophys Acta. 1981;661: 342-345.
12. Nielsen PJ, Manchester KL, Towbin H, Gordon J, Thomas G. The phosphorylation of ribosomal protein S6 in rat tissues following cycloheximide injection, in diabetes, and after denervation of diaphragm. A simple immunological determination of the extent of S6 phosphorylation on protein blots. J Biol Chem. 1982;257:12316-12321.
13. Igarashi K, Kashiwagi K, Hamasaki H, Miura A, Kakegawa T, Hirose S, Matsuzaki S. Formation of a compensatory polyamine by Escherichia coli polyamine requiring mutants during growth in the absence of polyamines. J Bacteriol. 1986;166:128-134.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
15. Matsui I, Wiegand L, Pegg AE. Properties of spermidine N-acetyltransferase from livers of rats treated with carbon tetrachloride and its role in the conversion of spermidine into putrescine. J Biol Chem. 1981;256: 2454-2459.
16. Wang Y, Devereux W, Woster PM, Stewart TM, Hacker A, Casero RA Jr. Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res. 2001;61: 5370-5373.
17. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304-1308.
18. Sakata K, Kashiwagi K, Sharmin S, Ueda S, Irie Y, Murotani N, Igarashi K. Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun. 2003;305:143-149.
19. Dog?an A, Rao AM, Hatcher J, Rao VLR, Baçskaya MK, Dempsey RJ. Effects of MDL 72527, a specific inhibitor of polyamine oxidase, on brain edema, ischemic injury volume, and tissue polyamine levels in rats after temporary middle cerebral artery occlusion. J Neurochem. 1999;72: 765-770.
20. Sekhon B, Sekhon C, Khan M, Patel SJ, Singh I, Singh AK. N-Acetylcysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res. 2004;971:1-8.
21. Lovell MA, Xie C, Markesbery WR. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging. 2001;22:187-194.
22. Deguchi K, Hayashi T, Nagotani S, Sehara Y, Zhang H, Tsuchiya A, Ohta Y. Tomiyama K, Morimoto N, Miyazaki M, Huh NH, Nakao A, Kamiya T, Abe K. Reduction of cerebral infarction in rats by billiverdin associated with amelioration of oxidative stress. Brain Res. 2008;1188:1-8.
23. Ohsawa I, Nishimaki K, Yasuda C, Kamino K, Ohta S. Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J Neurochem. 2003;84:1110-1117.
24. Ohsawa I, Ichikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13:688-694.
25. Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med. 1999;9:109-113.
26. Ivanova S, Batliwalla F, Mocco J, Kiss S, Huang J, Mack W, Coon A, Eaton JW, Al-Abed Y, Gregersen PK, Shohami E, Connolly ES Jr, Tracey KJ. Neuroprotection in cerebral ischemia by neutralization of 3-aminopropanal. Proc Natl Acad Sci U S A. 2002;99:5579-5584.
27. Zahedi K, Wang Z, Barone S, Prada AE, Kelly CN, Cassero RA, Yokota N, Porter CW Rabb H, Soleimani M. Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-perfusion injury. Am J Physiol Renal Physiol. 2003;284:F1046-F1055.
28. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, Topbas M, Aydin M, Eraydin I, Akcan B. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med. 2008;26:874-878.
29. Tanel A, Averill-Bates DA. Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteines. J Pharmacol Exp Ther. 2007;321: 73-83.
30. Igarashi K, Ueda S, Yoshida K, Kashiwagi K. Polyamines in renal failure. Amino Acids. 2006;31:477-483.